Introduction

 However they are associated with an increased incidence of severe and potentially blinding complications.
Introduction Introduction
 Photosensitisers are used as mediators of light induced cell toxicity.
 They act via the formation of reactive oxygen intermediates and free radicals.
 Selective activation of the photosensitiser by light application at the appropriate wavelength limits the drug effect on the targeted area. 
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Aim of the work
To evaluate the safety and efficacy of cellular photoablation using BCECF-AM as a method to control postoperative fibrosis in trabeculectomy compared to the effect of MMC combined with the same procedure in a rabbit model.
Because of the aggressive wound healing response in rabbits, this animal model is believed to be equivalent to high risk eyes in humans and surgical failure results within one week.  Study group (I): (7) right eyes had SST combined with intraoperative application of MMC (0.3mg/ml).
Materials and Methods
 Study group (II): (7) right eyes had SST combined with intraoperative application of BCECF-AM photosensitiser (dose of 80 μg in 300 μl BSS).
1-Preoperative
 IOP was recorded using hand held Perkin's applanation tonometer.
 To exclude cyclic variations, IOP was compared between the right and left fellow eye preand postop.
 The difference in measured IOP was expressed as right eye/left eye ratio
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2-Operations
Materials and Methods
 A single dose of BCECF-AM (80 μg in 300 μl BSS) was applied subconjunctivally in the region of the proposed filtering bleb.
 The injection was made 10 mm from the corneal limbus by a (27) gauge needle.
 A fornix-based conjunctival flap was performed.
 The episcleral and subconjunctival Tenon's were irradiated for 8 minutes, starting (15) minutes after the injection, with blue light provided by direct ophthalmoscope from a distance of approximately (10) cm.
3-Postoperative
 Tobradex eye drops 1X5 for 3weeks.
 All rabbits were examined daily for evaluation of the bleb morphology and detection of any postoperative complications.
 IOP was measured at day 1,3,5,7,14,21 postoperatively.  IOP ratio between the right and left eye < 0.8
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4-Histopathology
 Animals were sacrificed after 3weeks under general anesthesia.
 Eyes were enucleated, fixed in formaldehyde 10%.  The specimens were embedded in paraffin and sectioned.  Sections were stained with  Hematoxylin-Eosin Cellularity including fibroblast.
 Periodic acid -Schiff Goblet cell identification.
 Masson's Trichrome
Collagen density and architecture.
 Orcein stain Elastic fiber detection.
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Results
 No post-operative complication was observed.
 Bleb morphology at the end of 3 wks:  The mean % of reduction was 35.0 in the study group (I) with only one eye (14.3%) had 12.5% reduction.
 The mean percentage of reduction was 28.0 in the study group (II) with two eyes (28.6%) in study group (II) had 14.2% reduction each.
 Regarding the control group (II); the mean % of reduction was 14.3 with 5.0/14.0 (35.7%) eyes had > 20.0 % reduction.
 Histopathological results
Results
Conjunctiva of the control eyes shows abundant goblet cells (g) normal epithelial thickness and architecture , mild collagen (c) dispersion and scattered black elastic fibers (A:PAS X200, B:MT X200 and Orcein X400). 
SST
Discussion
 Though the applied carboxyfluorescein, as a lipophilic drug, could easily penetrate into adjacent superficial ocular tissues, no conjunctival or corneal-epithelial defect was observed in any eye postoperatively.
 The dye was applied preoperatively, subconjunctivally, and the tissue is irradiated before preparing the artificial fistula.
Therefore, it is unlikely for carboxyfluorescein to penetrate into the eye.
 As a consequence and as already proved by histological analyses of rabbit eyes treated with carboxyfluorescein, ciliary body toxicity was excluded.
Conclusion
 BCECF-AM treated eyes demonstrated favorable bleb morphology and histology.
 The stable density of goblet cells combined with modest fibroblast proliferation and collagen deposition suggest that the use of BCECF-AM may allow for the formation of thicker, more stable blebs.
 Use of BCECF-AM could allow for combination therapy with MMC or 5-FU at lower doses with decreasing the incidence of MMC related complications.
Cellular photoablation using BCECF-AM is a safe and effective wound modulating method to control postoperative fibrosis in trabeculectomy. However MMC considered as a more potent adjuvant to trabeculectomy than BCECF-AM in promoting IOP reduction.
